Clinical Trials
- HIV/AIDS
A Study to Evaluate Efficacy and Safety of Cabotegravir (CAB) Long Acting (LA) Plus (+) Rilpivirine (RPV) LA Versus BIKTARVY® (BIK) in Participants With Human Immunodeficiency Virus (HIV)-1 Who Are Virologically Suppressed (SOLAR)
- Ages18 years and older
- GenderBoth
- Date04/07/2021
- COVID-19 Vaccine
Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults
- Ages12 years and older
- GenderBoth
- Date08/12/2020
- Brain, Spinal Cord & Nervous System, HIV/AIDS, Infectious Disease, COVID-19 Inpatient, COVID-19 Outpatient
HIV Associated Reservoirs and Comorbidities (The HARC Plus Study)
- Date06/05/2015